title: [Effectiveness of Prevention of Mother to Child Transmission of Human Immunodeficiency Virus by the 2010 protocol of the World Health Organisation at the Medical Center St. Camille of Ouagadougou (Burkina Faso)].
authors.affiliation: Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Burkina Faso.
authors.forename: Solange Odile
authors.initials: SO
authors.lastname: Ouédraogo Yugbaré
authors.affiliation: Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Burkina Faso.
authors.forename: Nikaise
authors.initials: N
authors.lastname: Zagré
authors.affiliation: Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Burkina Faso.
authors.forename: Fla
authors.initials: F
authors.lastname: Koueta
authors.affiliation: Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Burkina Faso.
authors.forename: Lassina
authors.initials: L
authors.lastname: Dao
authors.affiliation: Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Service de pédiatrie du Centre Hospitalier Universitaire-Yalgado Ouédraogo.
authors.forename: Ludovic
authors.initials: L
authors.lastname: Kam
authors.affiliation: Unité de Formation et de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso; Centre Hospitalier Universitaire Pédiatrique Charles de Gaulle, Burkina Faso.
authors.forename: Diarra Yé
authors.initials: DY
authors.lastname: Ouattara
authors.affiliation: Unité de Formation et de Recherche en Sciences de la vie et de la terre, Ouagadougou, Burkina Faso; Centre médical saint Camille, Ouagadougou, Burkina Faso.
authors.forename: Jacques
authors.initials: J
authors.lastname: Simporé
mesh_terms: D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002050:Burkina Faso; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D015528:HIV Seroprevalence; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors; D014944:World Health Organization; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents
keywords: Burkina Faso; Option A; PMTCT; tritherapy